Eledon to present tegoprubart kidney-transplant rejection safety, efficacy
Eledon Pharmaceuticals said an oral presentation will cover long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection at the upcoming International Congress of The Transplantation Society.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.